StockData
Organon & Co. logo

Organon & Co. (OGN) KPIs and segments

OGNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 7/3013% above fair value
$13.92+0.02 (+0.14%)

Close on Nov 18, 2026Market cap $3.66BP/E 18.1Yield 2.44%

KPIs & segments

Operating metrics and segments that drive Organon's business

Organon's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Add to chartMetric
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Nexplanon/Implanon NXT($M)2
200230201210223240248259243242220231
United States($M)
127129127124146163176175172171153154
Intl($M)
7310174867777728470706776
Zetia($M)2
1019687909374857781758469
Intl($M)
1009586899172847580738266
United States($M)
121111122223
Other($M)2
939687858887788784722979
Intl($M)
919485828685768580692977
United States($M)
000411021000
Hadlima($M)2
867967696350474440283024
United States($M)
625551504736333329202215
Intl($M)
242416181614141111888
Atozet($M)2
8580856795867777125140132122
Intl($M)
8580856795867777125140132122
United States($M)
000000000000
Other Non-Opiod Pain, Bone and Dermatology($M)2
757968728080686874787268
Intl($M)
717565687576656769736865
United States($M)
343544445553
Arcoxia($M)2
696959707163625969687550
Intl($M)
696959707163625969687550
United States($M)
000000000000
Follistim AQ($M)2
675961586474696663624683
Intl($M)
354339354043343937403531
United States($M)
321721232430352526221151
Renflexis($M)2
676557617063576472696977
United States($M)
464442425146445256565562
Intl($M)
212115201917121216131414
Nasonex($M)2
655865656066727663607769
Intl($M)
655865646066717663607769
United States($M)
000000000000
Emgality($M)2
59545449514232382930100
Intl($M)
59545449514232382930100
United States($M)
000000000000
Cozaar/Hyzaar($M)2
515057535556555759606756
Intl($M)
494855515354535557586555
United States($M)
222222222232
Other Women's Health($M)2
454546464342433940344341
Intl($M)
292930292627272628232827
United States($M)
141517181714151514131516
Singulair($M)2
4548405953667484859398114
Intl($M)
4346385751647282839095111
United States($M)
222222222223
Diprospan($M)2
424435384141303737372933
Intl($M)
424435384141303737372933
United States($M)
000000000000
Vtama($M)2
4235253934312412000
United States($M)
3834233131292010000
Intl($M)
41283241000
Propecia($M)2
413630283332263228282333
Intl($M)
403428263130243127272132
United States($M)
121221112222
Dulera($M)2
354135353441435248475650
United States($M)
253023242432344238394340
Intl($M)
1011121110910111081310
Other Cardiovascular($M)2
352528283334303429323827
Intl($M)
342327273333303327313726
United States($M)
111211000100
Fosamax($M)2
282529364034333938354036
Intl($M)
282429354034323837343835
United States($M)
110000101111
Marvelon/Mercilon($M)2
283226243133393129413337
Intl($M)
283226243133393129413337
United States($M)
000000000000
Nuva Ring($M)2
252724162628222523293839
Intl($M)
191818181721161817192219
United States($M)
69697667101620
Vytorin($M)2
252121252527232626282829
Intl($M)
242020242526222425262729
United States($M)
111111121211
Ganirelix Acetate Injection($M)2
242626242227272726272922
Intl($M)
212424221925232420222317
United States($M)
422233545564
Bildyos/Bilprevda($M)2
241930
United States($M)
171430
Intl($M)
7500
Clarinex($M)2
233031302534342727353729
Intl($M)
233030292533342826353629
United States($M)
011111011111
Proscar($M)2
222026242722242223232620
Intl($M)
222026232722242223232620
United States($M)
000000000000
Brenzys($M)2
221420212322141427122428
Intl($M)
221420212322141427122428
United States($M)
000000000000
Other Respiratory($M)2
14181212121413181413912
United States($M)
11161110911101211877
Intl($M)
311323333434
Other Biosimilars($M)2
1312241467567
United States($M)
1010111133000
Intl($M)
2213334567
Ontruzant($M)2
765193131183420483962
United States($M)
45434546510810
Intl($M)
311162826142815383152
Rosuzet($M)2
5568664131191618
Intl($M)
5568664131191618
United States($M)
000000000000
Jada($M)2
005202018151816141312
Intl($M)
000000000000
United States($M)
005202018151815141313
Earlier reporting (last reported 2025)2
Intl($M)
1,1631,1601,1021,1351,1961,1801,1011,1761,1841,2191,2511,187
Europe and Canada($M)
417432412406417419376420436457450414
United States($M)
411398358372406414412416398388371411
Latin America, Middle East, Russia, and Africa($M)
269269247262286285240266243251274278
Asia Pacific and Japan($M)
234232226248251250251244260260287260
China($M)
226208194202219204204213212216206203
Other($M)
171923172322303333353432
Manufacturing facilities
666666666

18 metrics have no data in the last 12 quarters — .

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2026-10-30.

See a number that looks wrong?